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il
of 14 days) subjected to bedside leukodepletion and alloim-niversidade Estadual de Campinas (Unicamp), Campinas, SP, Braz
ed blood cell (RBC) alloimmunization is a signiﬁcant clin-
cal complication of transfusion-dependent patients; it is
elated to delays in obtaining matched blood as well as
otentially life-threatening delayed hemolytic transfusion
eactions (DHTRs), autoantibody formation, and hyperhe-
olysis syndrome.1 Because of its critical signiﬁcance, the
henomenon of RBC alloimmunization has been investigated
n a variety of settings. With a better understanding of the fac-
ors that predispose to RBC alloimmunization, it is possible to
evise strategies for blood transfusions that reduce the risk of
lloimmunization and adverse reactions to transfusion.
Clinical and biological factors such as disease state, human
eukocyte antigen (HLA) polymorphisms, underlying inﬂam-
ation, immunogenicity of the antigens and patient age are
ndependent variables involved in RBC alloimmunization.2 In
ddition, stored leukocyte-reduced RBCs have been reported
o produce higher rates of immunogenicity than fresh blood
n murine models.3 These ﬁndings led to speculate that the
ransfusion of older RBCs might create a cytokine burst that
redisposes a human recipient to RBC alloimmunization and
hus raised the interest of some groups to perform studies in
umans.
Some recent studies have suggested that RBC storage
ength is associated with adverse patient outcomes ranging
rom death to pneumonia to increased length of hospital and
ntensive care unit stays.4,5 RBC alloimmunization was cho-
en as an outcome in these studies because it can be both
edically and logistically problematic.6,7 By identifying asso-
iations, it may be possible to support or not support changing
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eserved.in the current inventory management practice of issuing the
oldest RBCs ﬁrst in chronically transfused patients.
Although there are few and limited studies showing the
effect of age of RBCs on alloimmunization in humans, some
studies did not note any association between the duration of
RBC storage and recipient alloimmune responses.8,9 However,
one recent study in patients with sickle cell disease (SCD) sug-
gested that RBC antibody formation is signiﬁcantly associated
with an older age of RBCs at the time of transfusion but this
study has limitations due to its retrospective design in which
inﬂammatory markers were not assessed and because of the
small number of patients with new antibody formation.10 The
differentiation of young versus old blood is another variable
that inﬂuences studies; most often, a storage period of 14 days
is used as a cutoff point to deﬁne older versus younger blood.
An important retrospective case–control study was per-
formed of a group of alloimmunized patients and non-
alloimmunized controls with solid cancer tumors that
received non-phenotyped RBC transfusions when the trans-
fusion of older RBC units was investigated as a risk factor for
alloimmunization.11 This was the ﬁrst human study that eval-
uated the risk of alloimmunization with the transfusion of
older RBCs that assured a similar inﬂammatory background
between the study groups. The authors assessed the associa-
tion between the transfusion of older RBC units (storage time):320–3.
480, Caixa-postal: 6198, Barão Geraldo, 13081-970 Campinas, SP,
munization in order to conﬁrm previous experimental results
and concluded that the transfusion of older RBC units is not a
key risk factor for alloimmunization in non-SCD patients. The
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ﬁndings of this study are very interesting and helpful clinically
and logistically as they do not reinforce previous experimen-
tal data and therefore do not support strategies of providing
fresher RBC units as a prophylaxis for alloimmunization.
Some factors known to inﬂuence RBC alloimmunization
identiﬁed in murine models are in the process of being inves-
tigated in humans. Although the results obtained by Dinardo
et al.11 are in agreement with other retrospective human
studies8,9 and strongly suggest that the transfusion of older
RBC units is not a risk factor for alloimmunization, we  should
consider that most studies are retrospective and do not com-
pare pre-transfusion samples to post-transfusion samples.
Therefore, it is unclear as to whether the presence of an
alloantibody is necessarily the result of a previous transfusion.
Further controlled prospective studies are probably neces-
sary. Another factor is that the underlying disease-associated
immunosuppression in association with chemotherapy may
suppress alloantibody production in patients with oncologic
disorders.
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